Rizatriptan Benzoate (Rizatriptan Benzoate)

Trade Name : Rizatriptan Benzoate

Bryant Ranch Prepack

TABLET

Strength 10 mg/1

RIZATRIPTAN BENZOATE Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Rizatriptan Benzoate (Rizatriptan Benzoate) which is also known as Rizatriptan Benzoate and Manufactured by Bryant Ranch Prepack. It is available in strength of 10 mg/1 per ml. Read more

Rizatriptan Benzoate (Rizatriptan Benzoate) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • Rizatriptan benzoate tablets,u00a0USPu00a0are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old.n n n
  • Rizatriptan benzoateu00a0u00a0tablets, USPu00a0is u00a0a u00a0serotonin u00a0(5-HT) receptor u00a0agonist u00a0(triptan) indicated for the acute treatment of migraine with or without aura in u00a0u00a0adults and in pediatric patients 6 to 17 years of age()n :
  • Use only after clear diagnosis of migraine has been established ()
  • Not indicated for the prophylactic therapy of migraine ()
  • Not indicated for the treatment of cluster headache ()
  • No data
  • Adults: 5 mgu00a0or 10 mg single dose; separate repeat doses by at least two hours; maximum dose in a 24-hour period: 30 mg ()
  • Pediatric patients 6 to 17 years: 5 mg single dose in patients < 40 kg (88 lb); 10 mg single dose in patients u2265 40 kg (88 lb) or more (2.2)
  • Adjust dose if co-administered with propranolol ()
  • Rizatriptan benzoate tablets, USP
  • Rizatriptan Benzoate Tablets, USP : 5 mg and 10 mg ()
  • Rizatriptan benzoateu00a0tablets, USP areu00a0contraindicated in patients with:
  • History of ischemic heart disease or coronary artery vasospasm ()
  • History of stroke or transient ischemic attack ()
  • Peripheral vascular disease ()
  • Ischemic bowel disease ()
  • Uncontrolled hypertension ()
  • Recent (within 24 hours) use of another 5-HT agonist (e.g., another triptan), or of an ergotamine-containing medication ()
  • Hemiplegic or basilar migraine ()
  • MAO-A inhibitor used in the past 2 weeks ()
  • Hypersensitivity to rizatriptan benzoate tablets, USPu00a0()
  • No data
  • Myocardial Ischemia, Myocardial Infarction, and Prinzmetal's Angina: Perform cardiac evaluation in patients with multiple cardiovascular risk factors ()
  • Arrhythmias: Discontinue dosing if occurs ()
  • Chest/throat/neck/jaw pain, tightness, pressure, or heaviness; Generally not associated with myocardial ischemia; Evaluate patients at high risk ()
  • Cerebral hemorrhage, subarachnoid hemorrhage, and stroke: Discontinue dosing if occurs ()
  • Gastrointestinal ischemic events, peripheral vasospastic reactions: Discontinue dosing if occurs ()
  • Medication Overuse Headache: Detoxification may be necessary ()
  • Serotonin Syndrome: Discontinue dosing if occurs ()
  • The following adverse reactions are discussed in more detail in other sections of the labeling:
  • The most common adverse reactions in adults were (incidence u22655% and greater than placebo): asthenia/fatigue somnolence, pain/pressure sensation and dizziness ()To report SUSPECTED ADVERSE REACTIONS, contact Ascend Laboratories, LLC at 1-877-ASC-RX01 (877-272-7901) or FDA at 1-800-FDA-1088 or .
  • No data
  • No data
  • Pregnancy: Based on animal data, may cause fetal harm ()
  • No overdoses of rizatriptan benzoate tablets, USP were reported during clinical trials in adults.Some adult patients who received 40 mg of rizatriptan benzoate tablets, USP either a single dose or as two doses with a 2-hour interdose interval had dizziness and somnolence.In a clinical pharmacology study in which 12 adult subjects received rizatriptan benzoate tablets, USP at total cumulative doses u00a0of u00a080 mg u00a0(given u00a0within u00a0four u00a0hours), u00a0two u00a0of u00a0the u00a0subjects u00a0experienced u00a0syncope, u00a0dizziness, bradycardia including third degree AV block, vomiting, and/or incontinence. n In the long-term, open label study, involving 606 treated pediatric migraineurs 12 to 17 years of age (of which 432 were treated for at least 12 months), 151 patients (25%) took two 10 mg doses of reizatriptan benzoate orally disintegrating tablets within a 24-hour period. Adverse reactions for 3 of these patients included abdominal discomfort, fatigue, and dyspnea.n n In addition, based on the pharmacology of rizatriptan benzoate tablets, USP hypertension or myocardial ischemia could occur after overdosage. Gastrointestinal decontamination, (i.e., gastric lavage followed by activated charcoal) should be considered in patients suspected of an overdose with rizatriptan benzoate tablets, USP. Clinical and electrocardiographic monitoring should be continued for at least 12 hours, even if clinical symptoms are not observed.n The effects of hemo- or peritoneal dialysis on serum concentrations of rizatriptan are unknown.
  • Rizatriptan benzoate tablet, USP contains, a selective 5-hydroxytryptamine (5-HT) receptor agonist.Rizatriptan benzoate, USP is described chemically as: -dimethyl-5-(1-1,2,4-triazol-1-ylmethyl)-1-indole-3-ethanamine monobenzoate and its structural formula is:
  • Its molecular formula is CHNu2022CHO, representing a molecular weight of the free base of 269.4. Rizatriptan benzoate is a white to off-white, crystalline solid that is soluble in water at about 42 mg per mL (expressed as free base) at 25u00b0C.Rizatriptan benzoate tablets, USP are available for oral administration in strengths of 5 mg and 10 mg (corresponding to 7.265 mg or 14.53 mg of the benzoate salt, respectively). Each compressed tablet contains the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, pregelatinized starch (maize), and magnesium stearate.
  • No data
  • No data
  • No data
  • Product: 71335-1283
  • NDC: 71335-1283-1 10 TABLET in a BOTTLE
  • NDC: 71335-1283-2 6 TABLET in a BOTTLE
  • NDC: 71335-1283-3 90 TABLET in a BOTTLE
  • NDC: 71335-1283-4 9 TABLET in a BOTTLE
  • NDC: 71335-1283-5 30 TABLET in a BOTTLE
  • NDC: 71335-1283-6 18 TABLET in a BOTTLE
  • NDC: 71335-1283-7 12 TABLET in a BOTTLE
  • See FDA-Approved Patient Labeling (Patient Information).n- Arrayn- [see , , , )]n- Arrayn- [see , , and ]n- Arrayn- [see ]n- Arrayn- [see ]n- Arrayn- Arrayn- [see ]n- Manufactured in India by:n- Distributed by:n
  • Parsippany, NJ 07054
  • Revised: 07/2016
  • Patient Information
  • RIZATRIPTAN BENZOATE TABLETS, USPn- 5 mg and 10 mgn- What is rizatriptan benzoaten- ?n- Who should not take rizatriptan benzoate tablets, USP?n- Do not take rizatriptan benzoate tablets, USP if you:
  • Talk to your doctor before taking this medicine if you have any of the conditions listed above or if you are not sure if you take any of these medicines. n n n n n tell your doctor if you:
  • Tell u00a0your u00a0doctor u00a0about u00a0all u00a0the u00a0medicines u00a0you u00a0take,n- Especially tell your doctor if you take:
  • Ask your doctor or pharmacist for a list of these medicines, if you are not sure. n Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.n n n
  • What should I avoid while taking rizatriptan benzoate tabletsn- USP?n- What are the possible side effects of rizatriptan benzoate tablets, USP?n- Rizatriptan benzoate tablets, USP may cause serious side effects
  • The most common side effects of rizatriptan benzoate tablets, USP in adults include:
  • Tell your doctor if you have any side effect that bothers you or that does not go away.n If you take rizatriptan benzoate tablets, USP too often, this may result in you getting chronic headaches. In such cases, you should contact your doctor, as you may have to stop taking rizatriptan benzoate tablets, USP.n These are not all the possible side effects of rizatriptan benzoate tablets, USP. For more information, ask your doctor or pharmacist.n Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.n n n
  • Keep rizatriptan benzoate tablets, USP and all medicines out of the reach of children.n- General Information about the safe and effective use of rizatriptan benzoate tablets, USP.
  • For more information contact Ascend Laboratories, LLC at 1-877-ASC-RX01 (877-272-7901n
  • What are the ingredients in rizatriptan benzoate tabletsn- USP? n- Active ingredient in rizatriptan benzoate tablets, USP:n- Inactive ingredients in rizatriptan benzoate tablets, USP:n- Manufactured in India by:n- Distributed by:n
  • Parsippany, NJ 07054
  • Revised: 07/2016
  • No data

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Dossiers and Stability Studies

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.